Drug Trial Radar · NCT07697456
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
2,000
Planned (sponsor's estimate)
Start
Jul 31, 2026
Primary completion
Oct 2031
Study completion Oct 2031
Sponsor
- Lead sponsor
- AbbVieAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Jul 13, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Crohn's disease (CD) and Ulcerative colitis (UC) are 2 types of inflammatory bowel diseases which cause long-lasting, severe inflammation (redness, swelling) in the digestive tract. CD can affect any part of the digestive tract causing many different symptoms including belly pain, diarrhea, tiredness, and weight loss. UC affects the lining of the rectum and colon (large intestine) and can cause bleeding, belly pain, and diarrhea. This platform basket study will evaluate how safe and effective advanced therapies are in adults with moderately to severely active Crohn's Disease (CD) or Ulcerative Colitis (UC). This study currently includes 2 substudies evaluating different treatments in participants with CD or UC. Substudy 1 will evaluate the combination of risankizumab and trosunilimab (ABBV-466) and Substudy 2 will evaluate the combination of risankizumab and ABBV-701 (ABBV-7066). When adult participants with moderately to severely active CD or UC join the study, they will undergo a 2-step randomization within CD and UC substudies, respectively. The first unblinded randomization will assign participants into a substudy, and the second blinded randomization will assign participants to a treatment arm within the assigned substudy. Approximately 100 adult participants will be enrolled per treatment arm across both substudies at approximately 400 sites worldwide. There may be higher treatment burden for participants in this trial compared to their standard of care treatment without participating in this study. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, stool tests, endoscopies, checking for side effects and completing questionnaires and a daily diary.
Conditions
- Crohn's Disease
- Ulcerative Colitis
Interventions
RisankizumabDrug
Intravenous/Subcutaneous/Intramuscular Injection/Infusion
TrosunilimabDrug
Intravenous/Subcutaneous/Intramuscular Injection/Infusion
ABBV-701Drug
Intravenous/Subcutaneous/Intramuscular Injection/Infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Crohn's Disease Specific: Percentage of Participants Achieving Endoscopic RemissionTime frame: At Week 28
- Ulcerative Colitis Specific: Percentage of Participants who Achieve Endoscopic RemissionTime frame: At Week 28
- Number of Participants with Adverse Events (AEs)Time frame: Up to 98 Weeks
Locations
66 sites in 5 countries. Site status is shown where the registry gives one.
Digestive Health Specialists /ID# 280827
Dothan, Alabama · Recruiting
Elite Clinical Studies /ID# 280477
Phoenix, Arizona · Recruiting
Gi Alliance - Arizona Digestive Health - Sun City /ID# 284084
Sun City, Arizona · Recruiting
Clinnova Research /ID# 280509
Anaheim, California · Recruiting
Southern California Res. Ctr /ID# 280476
Coronado, California · Recruiting
Gastro Care Institute /ID# 281071
Lancaster, California · Recruiting
United Medical Doctors - Los Alamitos /ID# 281125
Los Alamitos, California · Recruiting
Inland Empire Liver Foundation - Rialto /ID# 280775
Rialto, California · Recruiting
Peak Gastroenterology Associates - Colorado Springs - North Cascade Avenue /ID# 280507
Colorado Springs, Colorado · Recruiting
Synergy Healthcare - Bradenton /ID# 284157
Bradenton, Florida · Recruiting
Clinical Research of Osceola /ID# 280593
Kissimmee, Florida · Recruiting
Florida Center For Gastroenterology - Largo /ID# 281059
Largo, Florida · Recruiting
Research Associates of South Florida /ID# 280929
Miami, Florida · Recruiting
Advanced Research Institute, Inc /ID# 281062
New Port Richey, Florida · Recruiting
Digestive And Liver Center Of Florida - Orlando /ID# 280924
Orlando, Florida · Recruiting
Gcp Clinical Research /ID# 280469
Tampa, Florida · Recruiting
Gastroenterology Associates of Central Georgia /ID# 280464
Macon, Georgia · Recruiting
Gastroenterology Consultants - Roswell /ID# 281235
Roswell, Georgia · Recruiting
Treasure Valley Medical Research /ID# 281778
Boise, Idaho · Recruiting
Midwest Digestive Health & Nutrition /ID# 285250
Des Plaines, Illinois · Recruiting
Gi Alliance - Glenview /ID# 283932
Glenview, Illinois · Recruiting
Illinois Gastroenterology Group /ID# 283933
Gurnee, Illinois · Recruiting
Southwest Gastroenterology - Oak Lawn /ID# 280841
Oak Lawn, Illinois · Recruiting
Gastroenterology Health Partners /ID# 284145
New Albany, Indiana · Recruiting
Gastroenterology Health Partners /ID# 284144
Louisville, Kentucky · Recruiting
Gastro Group and Endocenter: Mandeville, la /ID# 284186
Mandeville, Louisiana · Recruiting
Metropolitan Gastroenterology Associates - Metairie /ID# 283922
Metairie, Louisiana · Recruiting
Willis-Knighton Medical Center /ID# 280572
Shreveport, Louisiana · Recruiting
Lucida Clinical Trials /ID# 282000
New Bedford, Massachusetts · Recruiting
West Michigan Clinical Research Center /ID# 280480
Wyoming, Michigan · Recruiting
Gi Associates - Gia And Endoscopy Center - Flowood /ID# 283967
Flowood, Mississippi · Recruiting
Gastroenterology Associates Of North Mississippi /ID# 285243
Oxford, Mississippi · Recruiting
Specialists In Gastroenterology /ID# 283939
St Louis, Missouri · Recruiting
Vector Clinical Trials /ID# 280843
Las Vegas, Nevada · Recruiting
New York Gastroenterology Associates - Upper East Side /ID# 281767
New York, New York · Recruiting
Digestive Health Partners /ID# 280490
Asheville, North Carolina · Recruiting
Dayton Gastroenterology - Beavercreek /ID# 284065
Beavercreek, Ohio · Recruiting
Gastro Intestinal Research Institute of Northern Ohio /ID# 283860
Westlake, Ohio · Recruiting
University Gastroenterology - Providence - Staniford Street /ID# 280919
Providence, Rhode Island · Recruiting
Gastroenterology Associates - Patewood /ID# 283870
Greenville, South Carolina · Recruiting
Showing 40 of 66 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.